Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival-Reference-Cited by-同舟云学术

Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival

Published:2005-08-26 Issue:6 Volume:68 Page:1636-1644
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Karnitz Larry M.,Flatten Karen S.,Wagner Jill M.,Loegering David,Hackbarth Jennifer S.,Arlander Sonnet J. H.,Vroman Benjamin T.,Thomas M. Bijoy,Baek Yong-Un,Hopkins Kevin M.,Lieberman Howard B.,Chen Junjie,Cliby William A.,Kaufmann Scott H.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication Stress

2. Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia

3. Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro

4. Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis.

5. ATM is required for the cellular response to thymidine induced replication fork stress

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies;Cancer Treatment Reviews;2024-09

2. Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells;Nature Cancer;2024-03-06

3. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone;Science of The Total Environment;2024-03

4. Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways;Journal of Pharmaceutical Sciences;2024-01

5. Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma;The Journal of Pathology: Clinical Research;2023-11-16